Products for Research Use Only

Gamitrinib TPP

CAT: 0013-GTR19205825-01Size: 25 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19205825-01Size:25 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Gamitrinib TPP
CAS Number
1131626-46-4
Field of Research
Metabolism Research, Signal Transduction
Smiles
CO[C@H]1C[C@H] (C) CC2=C (NCCCCCC[P+] (c3ccccc3) (c3ccccc3) c3ccccc3) C (=O) C=C (NC (=O) \C (C) =C\C=C/[C@H] (OC) [C@@H] (OC (N) =O) \C (C) =C\[C@H] (C) [C@H]1O) C2=O |c:7,48, t:40,46,59|
Molecular Formula
C52H65N3O8P
Molecular Weight
891.078
Storage Conditions
-20°C
Notes
For research use only.

Chemical Information

Gamitrinib

Gamitrinib is a resorcinolic-based mitochondrial-targeted heat shock protein 90 (Hsp90) family inhibitor, with potential antineoplastic activity. Upon administration, gamitrinib targets and inhibits the activity of Hsp90 heat shock proteins, such as TNF receptor-associated protein-1 (TRAP1). This induces the accumulation of the mitochondrial kinase PINK1 and the cytosolic E3 ubiquitin (Ub) ligase Parkin, ubiquitylates substrate proteins, and induces PINK1/Parkin-dependent mitophagy. Gamitrinib induces acute mitochondrial dysfunction, loss of membrane potential and membrane rupture leading to the induction of apoptosis in susceptible tumor cells. Hsp90, a chaperone complex protein upregulated in a variety of tumor cell types, regulates the folding and degradation of many oncogenic signaling proteins.

CAS Number1131626-46-4
PubChem CID25232582
IUPAC Name6-[[(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-9-carbamoyloxy-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-19-yl]amino]hexyl-triphenylphosphanium
Molecular FormulaC52H65N3O8P+
Molecular Weight891.1
XLogP7.8
Topological Polar Surface Area166
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count9
Rotatable Bond Count15
Heavy Atom Count64
Formal Charge1
Complexity1690
SMILES
C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCCCCCC[P+](C3=CC=CC=C3)(C4=CC=CC=C4)C5=CC=CC=C5)/C)OC)OC(=O)N)\C)C)O)OC
InChI
InChI=1S/C52H64N3O8P/c1-35-31-42-47(54-29-18-7-8-19-30-64(39-22-12-9-13-23-39,40-24-14-10-15-25-40)41-26-16-11-17-27-41)44(56)34-43(49(42)58)55-51(59)36(2)21-20-28-45(61-5)50(63-52(53)60)38(4)33-37(3)48(57)46(32-35)62-6/h9-17,20-28,33-35,37,45-46,48,50,57H,7-8,18-19,29-32H2,1-6H3,(H3-,53,54,55,56,58,59,60)/p+1/b28-20-,36-21+,38-33+/t35-,37+,45+,46+,48-,50+/m1/s1
InChIKey
OAUJLFPWRFHSNE-FEHIUCOBSA-O
Chemical Structure
2D Structure
2D structure of Gamitrinib
CAS: 1131626-46-4
CID: 25232582
Formula: C52H65N3O8P+
MW: 891.1
Interactive 3D Structure
Loading 3D structure...
Computed Properties
PropertyValue
Molecular Weight891.1
XLogP37.8
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count9
Rotatable Bond Count15
Exact Mass890.45092804
Monoisotopic Mass890.45092804
Topological Polar Surface Area166 Ų
Heavy Atom Count64
Formal Charge1
Complexity1690
Isotope Atom Count0
Defined Atom Stereocenter Count6
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count3
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count1
Compound Is CanonicalizedYes